These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Interactions of antiestrogens with human breast cancer in long-term tissue culture. Lippman M, Bolan G, Huff K. Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504 [Abstract] [Full Text] [Related]
9. Antiestrogen pharmacology and mechanism of action. Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K. J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873 [Abstract] [Full Text] [Related]
10. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity. Murphy CS, Parker CJ, McCague R, Jordan VC. Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879 [Abstract] [Full Text] [Related]
11. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture. Jain PT, Pento JT, Magarian RA. Anticancer Res; 1992 Mar; 12(3):585-90. PubMed ID: 1622114 [Abstract] [Full Text] [Related]
12. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor. Jasper TW, Ruh MF, Ruh TS. J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371 [Abstract] [Full Text] [Related]
13. Antiestrogen interaction with estrogen receptors and additional antiestrogen binding sites in human breast cancer MCF-7 cells. Ahn MR, Sheen YY. Arch Pharm Res; 1997 Dec; 20(6):579-85. PubMed ID: 18982263 [Abstract] [Full Text] [Related]
14. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Benz C, Hollander C, Miller B. Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973 [Abstract] [Full Text] [Related]
15. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7. Roos W, Oeze L, Löser R, Eppenberger U. J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210 [Abstract] [Full Text] [Related]
17. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Coezy E, Borgna JL, Rochefort H. Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859 [Abstract] [Full Text] [Related]
18. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. Cancer Res; 1987 Aug 15; 47(16):4355-60. PubMed ID: 3607768 [Abstract] [Full Text] [Related]
19. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line. Poulin R, Labrie F. Cancer Res; 1986 Oct 15; 46(10):4933-7. PubMed ID: 2944574 [Abstract] [Full Text] [Related]
20. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Reddel RR, Murphy LC, Sutherland RL. Cancer Res; 1983 Oct 15; 43(10):4618-24. PubMed ID: 6883318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]